ENDOCARE INC (ENDO) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 151 transactions totaling $2.9M, demonstrating a bullish sentiment with $2.3M in net insider flow. The most recent transaction on Feb 9, 2016 involved a transaction of 5,000,000 shares valued at $0.
No significant insider buying has been recorded for ENDO in the recent period.
No significant insider selling has been recorded for ENDO in the recent period.
Based on recent SEC filings, insider sentiment for ENDO is bullish with an Insider Alignment Score of 89/100 and a net flow of $2.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ENDOCARE INC (ENDO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading ENDO stock, having executed 151 transactions in the past 90 days. The most active insider is Clint Davis (Executive), who has made 21 transactions totaling $4.6M.
Get notified when executives and directors at ENDO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 9, 2016 | Steven Johnson Chad | Executive | Award | 5,000,000 | $N/A | $0 | |
| Jan 19, 2016 | Steven Johnson Chad | Executive | Award | 5,000,000 | $N/A | $0 | |
| Jan 19, 2016 | Dorothy H. Bray Dr | Executive | Award | 5,000,000 | $N/A | $0 | |
| Jan 18, 2016 | Dorothy H. Bray Dr | Executive | Award | 5,000,000 | $N/A | $0 | |
| Jun 30, 2015 | Dorothy H. Bray Dr | Executive | Award | 5,000,000 | $N/A | $0 | |
| Jul 27, 2009 | R. Testman Thomas | Executive | Tender | 5,000 | $N/A | $0 | |
| Jul 27, 2009 | R. Testman Thomas | Executive | Tender | 62,360 | $N/A | $0 | |
| Jul 27, 2009 | R. Testman Thomas | Executive | Option Exercise | 53,158 | $N/A | $0 | |
| Jul 27, 2009 | R. Testman Thomas | Executive | Option Exercise | 9,202 | $N/A | $0 | |
| Jul 27, 2009 | Davis Clint | Executive | Payment | 14,300 | $N/A | $0 | |
| Jul 27, 2009 | Davis Clint | Executive | Tender | 55,773 | $N/A | $0 | |
| Jul 27, 2009 | Davis Clint | Executive | Payment | 1,827 | $N/A | $0 | |
| Jul 27, 2009 | Davis Clint | Executive | Option Exercise | 6,156 | $N/A | $0 | |
| Jul 27, 2009 | Davis Clint | Executive | Option Exercise | 40,000 | $N/A | $0 | |
| Jul 27, 2009 | L. Goldsmith David | Executive | Tender | 1,000 | $1.35 | $1.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 22 | $5.1M | 63.3% |
Purchase(P) | 54 | $2.6M | 31.8% |
Sale(S) | 17 | $331.9K | 4.1% |
Tender(U) | 14 | $63.1K | 0.8% |
Award(A) | 5 | $0 | 0.0% |
Exercise(M) | 39 | $0 | 0.0% |
Insiders at ENDOCARE INC are accumulating shares at an accelerated pace. With 16 insiders making 151 transactions totaling $2.6M in purchases versus $331.9K in sales, the net buying activity of $2.3M signals strong executive confidence. Clint Davis (Executive) leads the buying activity with $4.6M in transactions across all time.